In-frame insertion/duplication in EGFR ex20 comprises 4%–12% of all EGFR mutations in NSCLC (14–16) and represents a distinct subset of EGFR-mutated NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.